4.3 Article

ANXA1 inhibits miRNA-196a in a negative feedback loop through NF-kB and C-Myc to reduce breast cancer proliferation

Journal

ONCOTARGET
Volume 7, Issue 19, Pages 27007-27020

Publisher

IMPACT JOURNALS LLC
DOI: 10.18632/oncotarget.8875

Keywords

microRNAs; breast cancer; annexin 1; pri-miR-196a; c-myc; Immunology and Microbiology Section; Immune response; Immunity

Funding

  1. National Kidney Foundation of Singapore [NKFRC 2011/01/05]
  2. NUHS [R185-000-257-112]
  3. NMRC CS_IRG [R713-000-163-511]
  4. National University of Singapore

Ask authors/readers for more resources

MiRNAs are endogenous similar to 22 nt RNAs which play critical regulatory roles in a wide range of biological and pathological processes, which can act as oncogenes or tumor suppressor genes depending on their target genes. We have recently shown that ANXA1 inhibits the expression of miRNAs including miR196a. Here, we show that miR196a was highly expressed in ER+MCF-7 breast cancer cells when compared to normal mammary gland cells, with expression levels negatively correlating to ANXA1. ANXA1 inhibits the biogenesis of oncogenic miR-196a by suppressing primary-miR196a indirectly through the stimulation of c-myc and NFkB expression and activity in breast cancer cells. In a negative feedback loop, miR-196a directly inhibits ANXA1 and enhances breast cancer cell proliferation in vitro. Finally, miR196a promotes breast tumor growth in vivo. This study reports a novel regulatory circuit between ANXA1, NF-kB, c-myc and miR-196a which regulates breast cancer cell proliferation and tumor growth.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available